Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Concentration of Mirabegron”

3 trials

Showing 3 of 3 results

Early research (Phase 1)Study completedNCT01720212
What this trial is testing

Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers

Who this might be right for
Healthy Chinese Volunteers
Astellas Pharma China, Inc. 24
Early research (Phase 1)Study completedNCT01747564
What this trial is testing

Evaluate Absorption, Distribution and Elimination of Mirabegron After Oral Administration to Non-elderly Healthy Chinese Subjects

Who this might be right for
Healthy SubjectsPlasma Concentration of Mirabegron
Astellas Pharma Inc 24
Post-approval studies (Phase 4)Study completedNCT01964183
What this trial is testing

Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine

Who this might be right for
Pharmacokinetics of Mirabegron and TolterodineHealthy
Astellas Pharma Inc 24

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation